Milestone Pharmaceuticals to Report Q2 Results on August 12

MIST Milestone Pharmaceuticals Inc

$0.66 -1.06%

View chart & analysis →

1. 1Milestone Pharmaceuticals (MIST) will report its second-quarter results on August 12, 2026.
2. 2The Q2 consensus calls for revenue of $820,000 and a loss per share of -$0.19.
3. 3The annual revenue estimate has been cut over the past 90 days from $37.96 million to $5.39 million.

Source GuruFocus.com +2 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →